Pinealon 20mg Research Peptide

Pinealon 20mg is a synthetic tripeptide research compound composed of Glu–Asp–Arg, commonly referred to as the EDR peptide. Supplied as a lyophilized powder with a reported purity greater than 99%, Pinealon 20mg has been studied in laboratory and preclinical models for its interaction with central nervous system–related pathways, oxidative stress mechanisms, and cellular regulation processes. Pinealon 20mg is intended exclusively for laboratory research use.

What Is Pinealon 20mg?

Pinealon 20mg is a short peptide derived from research on Cortexin, a low–molecular weight polypeptide investigated for its ability to cross the blood–brain barrier in experimental settings. Due to its small molecular size and amino acid composition, Pinealon has been examined for its potential to interact with neuronal signaling pathways, cellular stress responses, and gene-regulatory mechanisms in controlled research environments.

Pinealon 20mg is an experimental research peptide and is not approved for human or animal use.

Research Background

Research into Pinealon has focused on its potential influence on neuronal survival, oxidative stress modulation, and cellular aging processes. Experimental findings suggest that Pinealon may demonstrate concentration-dependent activity, with different biological interactions observed at varying exposure levels.

In laboratory studies, Pinealon has been investigated for its possible ability to penetrate the blood–brain barrier and interact with DNA molecules, prompting interest in its role in gene expression regulation and cellular protection mechanisms. All findings remain preclinical and have not been validated in human clinical trials.

Mechanisms of Research Interest

MAPK/ERK Signaling Pathway Modulation

Pinealon 20mg has been studied for its potential interaction with mitogen-activated protein kinase and extracellular signal–regulated kinase pathways, which are involved in neuronal plasticity, metabolic stress responses, and apoptosis-related signaling.

Oxidative Stress Research

Experimental models suggest Pinealon may influence the synthesis of reactive oxygen species, potentially reducing oxidative stress–associated cellular damage in research settings.

Cell Cycle and Genomic Interaction Research

At higher experimental concentrations, Pinealon has been examined for its potential interaction with DNA and its ability to influence cell cycle progression and gene regulatory processes.

Neuroprotection Research

Pinealon 20mg has been investigated in laboratory models assessing neuronal resilience and cellular protection under conditions of oxidative or metabolic stress.

All mechanisms described are experimental observations or theoretical models and do not imply clinical or therapeutic benefit.

Molecular and Chemical Information

• Product Name: Pinealon 20mg

• Form: Lyophilized powder

• Purity: Greater than 99%

• Peptide Length: 3 amino acids (tripeptide)

• Amino Acid Sequence: Glutamate–Aspartate–Arginine

• Molecular Formula: C15H26N6O8

• Molecular Weight: 418.4 g/mol

• Alternate Names: EDR, Glu–Asp–Arg

Research Applications

Pinealon 20mg may be utilized by qualified researchers in laboratory investigations involving:

• Central nervous system signaling research

• Oxidative stress and antioxidant pathway studies

• Neuroprotection and neuronal survival models

• Gene expression and cell cycle regulation research

All use must remain within controlled laboratory environments.

Regulatory Status and Use Disclaimer

• For research use only

• Not approved by the Food and Drug Administration

• Not intended for human or veterinary use

• Not intended to diagnose, treat, cure, or prevent any disease

• No established clinical safety, dosing, or efficacy data